Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Drug Discovery
Transitioning existing LC methods to new technologies
Choosing a liquid chromatography platform for 2012
Pfizer’s bounce back?
What do you do after your most promising, late-stage experimental drug – expected to be one of the best-selling pharmaceuticals in history – gets its walking papers? Tell anyone and everyone about everything else in your pipeline.
Innovate or die
The pharmaceutical industry has developed something of a poor reputation due to pricing issues and drug safety problems.
The change agent
Merck & Co., Inc. has been big pharma since the early 1900s – but recent years have seen it suffer its fair share of problems in the pipeline. Can the vaccination king future-proof itself? Damien Munroe spoke with Tony Ford Hutchinson, the company’s Executive Vice President of Research Medicine, to find out.
Endgame: nothing short of breakthrough science
At the beginning of the 21st century, the fittingly named Millennium will not settle for anything less. Joe Bolen, Chief Scientific Officer, explains why.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.